$ALLE

Allegion insiders sold shares. Timothy P. Eckersley sold 6,364 shares at $178.62 each, totaling $1.14M. Kemp Tracy L sold 4,469 shares at $178.805 each, totaling $799,079. Both retained significant holdings.

Eckersley Timothy P (President-Intl & SVP-Allegion) sold 6,364 shares of Allegion plc (ALLE) at $178.62 ($1.14M total) on 2026-10-26.

Kemp Tracy L (SVP-Chief Info. & Digital Ofr) sold 4,469 shares of Allegion plc (ALLE) at $178.80 ($0.80M total) on 2026-10-26.

Analysts updated ratings and price targets for various U.S. companies. Notable changes include downgrades for 10x Genomics (TXG) and upgrades for Allegion (ALLE). Price targets were raised for AbbVie (ABBV), Amgen (AMGN), and others, while cuts were seen in sectors like retail and housing. Analysts favored growth and defensive sectors while showing caution toward consumer-sensitive areas.

Analysts raised Allegion plc's 12-month price target to $191.7, up from $186.4, with a 9% upside based on Oct. 22 closing price. The consensus rating remains 'Buy' among 14 analysts, with 9 Buys and 5 Holds.

ALLE reported Q3 revenue of $1.17B, beating estimates, with adjusted EPS of $2.60 and EBITDA of $308M. Management raised full-year EPS guidance to $9.08. Growth was driven by Americas Non-Residential demand, electronics, and pricing strategies. International segment faced volume weakness. The company completed acquisitions and invested in AI technology.

Analysts made several calls on Friday. Roth initiated Natera and Guardant Health with buy ratings, targeting $475 and growth respectively. PhillipCapital upgraded SpaceX to buy with a $250 price target. Seaport reiterated Nvidia as sell due to competitive pressures. Barclays initiated Rush Street Interactive at overweight. Piper Sandler downgraded Deckers to underweight. Jefferies upgraded MSC Industrial to buy. Citizens initiated Microbot Medical at market outperform.

Allegion highlights its competitive advantages, including a strong specification-writing network and large installed base. The company is monitoring input cost inflation and pricing, while making targeted acquisitions like Overly Door Company for $90 million. Share repurchases are also being used to return excess cash to investors, according to management.

AI stocks fell sharply, led by Meta (META) and Lam Research (LRCX), due to rising AI costs and supply constraints. Nasdaq dropped 2.6%, S&P 500 fell 1.2%. Defensive sectors like Staples and Health Care rose. Treasuries rallied as 10-year yield fell to 4.95%. Tesla (TSLA) and Nvidia (NVDA) also declined.

Allegion's Q3 adjusted EPS of $2.60 and revenue of $1.17B beat estimates. Management raised 2026 adjusted EPS outlook to $9.05-$9.10. Growth was driven by the Americas, while International sales declined. Shares rose 11%.